País: Estados Unidos
Língua: inglês
Origem: NLM (National Library of Medicine)
Piperacillin Sodium (UNII: M98T69Q7HP) (Piperacillin Anhydrous - UNII:9I628532GX)
X-GEN Pharmaceuticals, Inc.
Piperacillin Sodium
Piperacillin Anhydrous 3 g in 20 mL
PRESCRIPTION DRUG
Unapproved drug for use in drug shortage
PIPERACILLIN, TAZOBACTAM- PIPERACILLIN, TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION X-GEN PHARMACEUTICALS, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- TEMPORARY IMPORTATION OF CANADIAN PIPERACILLIN AND TAZOBACTAM FOR INJECTION TO ADDRESS DRUG SHORTAGE January 16, 2017 Dear Healthcare Professional: Due to the current critical shortage of Piperacillin and Tazobactam for Injection products in the United States (U.S.) market, SteriMax Inc. (SteriMax) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of the drug. SteriMax has initiated temporary importation of non-FDA approved Piperacillin and Tazobactam for Injection (3.375 g/vial, 4.5 g/vial, and 40.5 g/vial) into the U.S. market. The Piperacillin and Tazobactam for Injection from SteriMax is marketed in Canada and is manufactured at an FDA-inspected facility that is in compliance with current good manufacturing practice requirements. X-Gen Pharmaceuticals will distribute SteriMax's Piperacillin and Tazobactam for Injection to address the critical shortage. At this time, no other entity except SteriMax or its distributor X-Gen Pharmaceuticals is authorized by the FDA to import or distribute SteriMax's Piperacillin and Tazobactam for Injection in the United States. Effective immediately, X-Gen Pharmaceuticals will distribute the following presentations of SteriMax's Piperacillin and Tazobactam for Injection: STERIMAX PIPERACILLIN AND TAZOBACTAM FOR INJECTION 3.375 g/vial (equivalent to 3 g of piperacillin and 0.375 g of tazobactam) DIN: 02362627 (Canada) 4.5 g/vial (equivalent to 4 g of piperacillin and 0.5 g of tazobactam) DIN: 02362635 (Canada) 40.5 g/vial (equivalent to 36 g of piperacillin and 4.5 g of tazobactam) DIN: 02439131 (Canada) Note: DIN refers to Drug Identification Number for products marketed in Canada. THE BARCODE MAY NOT REGISTER ACCURATEL Leia o documento completo